LD-2 disclosure · 2nd Quarter - Report
BIOMARIN PHARMACEUTICAL INC.
via BIOMARIN PHARMACEUTICAL INC.
Client
- Name
- BIOMARIN PHARMACEUTICAL INC.
- Location
- California · United States of America
Registrant
- Firm
- BIOMARIN PHARMACEUTICAL INC.
- Description
- Develops and commercializes biopharmaceuticals.
- Location
- San Rafael, California, United States of America
Lobbying activities
3 issuesHealth Issues
HR 4472: BETTER EMPOWERMENT NOW TO ENHANCE FRAMEWORK AND IMPROVE TREATMENTS (BENEFIT) ACT OF 2021; ALL PROVISIONS OF THE BILL HR 6000: CURES 2.0 ACT: PROVISIONS RELATED TO SECTIONS 203, 204, 303-309, 402, 403, 407 HR 6584: DIVERSE AND EQUITABLE PARTICIPATION IN CLINICAL TRIALS (DEPICT) ACT; ALL PROVISIONS OF THE BILL HR 6888: HELPING EXPERTS ACCELERATE RARE TREATMENTS ACT OF 2022; ALL PROVISIONS OF THE BILL HR 6963: ACCELERATED APPROVAL INTEGRITY ACT OF 2022; ALL PROVISIONS OF THE BILL HR 6996: ACCELERATING ACCESS FOR PATIENTS ACT OF 2022; ALL PROVISIONS OF THE BILL HR 7667: FOOD AND DRUG AMENDMENTS OF 2022; PROVISIONS RELATED TO TITLE V, SECTIONS 703 AND 804 S 373: BETTER EMPOWERMENT NOW TO ENHANCE FRAMEWORK AND IMPROVE TREATMENTS (BENEFIT) ACT OF 2021; ALL PROVISIONS OF THE BILL S 4071: HELPING EXPERTS ACCELERATE RARE TREATMENTS ACT OF 2022; ALL PROVISIONS OF THE BILL S 4348: FOOD AND DRUG ADMINISTRATION SAFETY AND LANDMARK ADVANCEMENTS ACT OF 2022 (FDASLA ACT); PROVISIONS RELATED TO SECTION 506 GENERAL DISCUSSIONS REGARDING ISSUES AFFECTING GENETIC BONE DISORDERS GENERAL DISCUSSIONS REGARDING HEMOPHILIA GENE THERAPY
LobbyistsKATHRYN LOWELL · JOHN EDWARD GREISSING
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
HR 7389: MEDICAID VBPS FOR PATIENTS (MVP) ACT: ALL PROVISIONS OF THE BILL S 2164: LOWER COSTS, MORE CURES ACT OF 2021; PROVISIONS RELATED TO SECTIONS 121-123 GENERAL DISCUSSIONS REGARDING TELEMENTAL HEALTH DISCUSSION DRAFT GENERAL DISCUSSIONS REGARDING MEDICAID ACCESS TO RARE DISEASE THERAPIES, TELEHEALTH, AND HOME INFUSION
LobbyistsJOHN EDWARD GREISSING
SENATE · HOUSE OF REPRESENTATIVES
